Christopher Campbell

Christopher Campbell, Pharm.D., BCOP, currently serves as Sr. Field Medical Director at BeiGene since August 2024. Previously, Christopher held the position of Sr. Medical Science Liaison at MorphoSys from May 2023 to August 2024, providing medical support for key opinion leaders and engaging in clinical operations for various oncology therapies. Prior roles include Associate Director of US Field Medical Strategy and Scientific Engagement and Senior Medical Science Liaison at Eisai US, where Christopher contributed to oncology strategies and leadership initiatives. Clinical experience was further solidified as a Clinical Oncology/Hematology Pharmacist at Northwestern Memorial Hospital, along with management experience in advanced practice pharmacy at Blue Cross and Blue Shield. Christopher's educational background includes a Doctor of Pharmacy from the University of Illinois Chicago and a Data Science Certificate from the University of California, Berkeley.